Arhalofenate is a dual-acting small molecule being developed by CymaBay Therapeutics for the treatment of gout, offering both urate-lowering and anti-inflammatory effects.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.